Bulletin
Investor Alert

New York Markets Open in:

Biogen Inc.

NASDAQ: BIIB

GO
/marketstate/country/us

Before the Bell

/quotes/zigman/91573/composite

$

277.72

Change

-1.05 -0.38%

Volume

Volume 446

Dec 20, 2016, 7:08 a.m.

Real time quotes

/quotes/zigman/91573/composite

Previous close

$ 278.77

$ 278.77

Change

-7.63 -2.66%

Day low

Day high

$272.96

$290.51

Open
Open: 286.59

52 week low

52 week high

$223.02

$333.65

Open

Market cap

$62.31B

Average volume

1.85M

P/E ratio

15.75

Rev. per Employee

$1.47M

EPS

17.69

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Biogen shares slip following announcement of new CEO

    4:30 p.m. Dec. 19, 2016

    - Wallace Witkowski

  2. Mizuho's Salim Syed says patient with seizure in Biogen study raises 'new potential safety issue'

    3:06 p.m. Dec. 9, 2016

    - Emma Court

  3. Biogen Inc. drops 0.3% after day of 5% gains

    3:04 p.m. Dec. 9, 2016

    - Emma Court

  4. Biogen surges 5.5% on presentation of Eli Lilly Alzheimer's drug trial results

    10:07 a.m. Dec. 9, 2016

    - Emma Court

  5. Biogen shares rise 1.6% on leaked Alzheimer's drug data

    4:06 p.m. Dec. 8, 2016

    - Emma Court

  6. CORRECTED: Biogen shares rise 1.5% on leak of its Alzheimer's drug data

    3:59 p.m. Dec. 8, 2016

    - Emma Court

  7. Biogen shares down 6.6% in premarket trade

    8:09 a.m. Nov. 23, 2016

    - Ciara Linnane

  8. 5 big hurdles to repealing Obamacare

    8:56 a.m. Nov. 14, 2016

    - Michael Brush

  9. Biogen shares up 3.9% premarket; Ionis shares up 12.3%

    8:38 a.m. Nov. 7, 2016

    - Ciara Linnane

  10. Biogen and Ionis report positive results of Phase 3 trial of treatment for spinal muscular atrophy

    8:38 a.m. Nov. 7, 2016

    - Ciara Linnane

  11. This key Nasdaq gauge is topping out and Apple isn’t helping

    10:04 a.m. Oct. 26, 2016

    - Barbara Kollmeyer

  12. Biogen profit beats estimates on sales of MS drug

    7:55 a.m. Oct. 26, 2016

    - MarketWatch.com

  13. Loading more headlines...
Get more info »

Where does this data come from?

Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.

Sentiment on BIIB

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Biogen Names New CEO

    5:22 p.m. Dec. 19, 2016

    - The Wall Street Journal Interactive Edition

  2. Biogen Names Insider New CEO After Five-Month Search, Stock Falls

    4:04 p.m. Dec. 19, 2016

    - Investors Business Daily

  3. 3 Low-Volatility Biotech Stocks to Buy

    1:22 p.m. Dec. 18, 2016

    - Motley Fool

  4. Outlook 2017: This Bull Market Has Legs

    3:33 a.m. Dec. 17, 2016

    - Barrons.com

  5. Today's ratings action

    12:58 p.m. Dec. 16, 2016

    - Seeking Alpha

  6. Dupixent Might Help Diversify Regeneron’s Business Model

    10:50 a.m. Dec. 15, 2016

    - MarketRealist.com

  7. SOLO 1 and SOLO 2 Trials Could Strengthen Dupixent’s Label

    10:50 a.m. Dec. 15, 2016

    - MarketRealist.com

  8. Dupixent Is Being Explored for Multiple Indications in 2016

    10:50 a.m. Dec. 15, 2016

    - MarketRealist.com

  9. 3 Small-Cap Biotech Stocks on the Rise in 2017

    12:01 p.m. Dec. 14, 2016

    - InvestorPlace.com

  10. Moat Investing: Stay Ahead of the Competition

    10:22 a.m. Dec. 14, 2016

    - MarketRealist.com

  11. How to Add ‘Moativated’ Stocks to Your Portfolio

    10:22 a.m. Dec. 14, 2016

    - MarketRealist.com

  12. My Dashboard Stock Lists: 25% In 1 Year, Part 2

    10:17 a.m. Dec. 14, 2016

    - Seeking Alpha

  13. 3 Top Biotech Stocks to Buy on Sale

    5:43 p.m. Dec. 13, 2016

    - Motley Fool

  14. Top Research Reports for Barclays, Netflix and Nike

    11:04 a.m. Dec. 13, 2016

    - Zacks.com

  15. Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits

    9:45 a.m. Dec. 13, 2016

    - InvestorPlace.com

  16. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Biogen Names Michel Vounatsos Chief Executive Officer

    4:20 p.m. Dec. 19, 2016

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

5 yr CD
1.2%
2 yr CD
0.8%
1 yr CD
0.6%
MMA $10K+
0.3%
MMA $50K+
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 12.00% 12.00% 11.98%
Business 13.16% 13.16% 13.12%
Student 13.42% 13.42% 13.42%
Balance Transfer 14.44% 14.41% 14.38%
Airline 15.15% 15.15% 15.08%
Reward 15.27% 15.25% 15.29%
Cash Back 15.38% 15.33% 15.32%
Instant Approval 17.86% 17.86% 18.04%
Bad Credit 22.86% 22.86% 22.56%
Source:CreditCards.com
Trending Tickers
  • /quotes/zigman/19622165/composite BBRY+1.72%
  • /quotes/zigman/85163/composite ACAD-2.12%
  • /quotes/zigman/80597/composite NVDA+1.22%
  • /quotes/zigman/235840/composite NKE-0.14%
  • /quotes/zigman/7305462/composite CLVS+8.82%
X
Powered by StockTwits
Link to MarketWatch's Slice.